MedTrace Logo

Efficacy and Safety of Metformin in Preventing Patients With Risperidone From Weight Gain and Amenorrhea

NCT01423487 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2012-08-02

No results posted yet for this study

Summary

Some previous studies has demonstrated that Metformin can improve the weight gain which caused by antipsychotics. An our study, which will be published, also found that Metformin can improve the amenorrhea for patients with antipsychotics, approximately 60% patients recovery period. So the present study was designed to investigate the efficacy and safety of Metformin in preventing patients with Risperidone from weight gain and amenorrhea.

Conditions

  • Weight Gain
  • Amenorrhea

Interventions

DRUG

Metformin

0.5g bid 26 weeks

OTHER

Starch tablets

0.5g bid 26 weeks

Sponsors & Collaborators

  • Central South University

    lead OTHER

Principal Investigators

  • Jing-Ping Zhao, Dr., Ph.D. · Mental Health Institute of The Second Xiangya Hospital, Central South University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-02-28
Completion
2013-08-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01423487 on ClinicalTrials.gov